Nidan Laboratories and Healthcare Limited (NSE:NIDAN)

NSE:NIDAN Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	271.16	245.28	241.77	242.66	296.6	207.92
Revenue Growth (YoY)	18.48%	1.45%	-0.36%	-18.19%	42.65%	-6.27%
Cost of Revenue	18.97	19.53	21.93	24.67	37.7	23.82
Gross Profit	252.18	225.74	219.84	217.99	258.9	184.1
Selling, General & Admin	50.43	47.63	48.62	51.58	38.54	27.6
Other Operating Expenses	150.02	125.81	106.78	98.37	126.22	67.63
Operating Expenses	220.4	197.53	184.06	180.94	191.07	127.08
Operating Income	31.78	28.22	35.78	37.05	67.83	57.03
Interest Expense	-20.72	-20.66	-20.86	-20.95	-24.35	-34.62
Interest & Investment Income	20.46	20.46	26.46	28.84	0.05	-
Other Non Operating Income (Expenses)	0.65	-0.73	0.05	0.48	-1.22	10.61
EBT Excluding Unusual Items	32.18	27.29	41.44	45.43	42.31	33.02
Gain (Loss) on Sale of Assets	0.32	0.32	-	2.69	2.89	-
Other Unusual Items	-	-	-65.13	-	-	-
Pretax Income	32.5	27.6	-23.69	48.12	45.2	33.02
Income Tax Expense	9.4	7.83	8.64	12.72	18.58	10
Net Income	23.09	19.77	-32.32	35.4	26.63	23.02
Net Income to Common	23.09	19.77	-32.32	35.4	26.63	23.02
Net Income Growth	-	-	-	32.92%	15.66%	222.19%
Shares Outstanding (Basic)	14	14	14	14	11	10
Shares Outstanding (Diluted)	14	14	14	14	11	10
Shares Change (YoY)	-0.11%	-	-	21.22%	15.83%	-
EPS (Basic)	1.66	1.42	-2.33	2.55	2.32	2.33
EPS (Diluted)	1.66	1.42	-2.33	2.55	2.32	2.33
EPS Growth	-	-	-	9.76%	-0.24%	222.19%
Free Cash Flow	18.33	13.36	47.84	103.01	7.53	12.18
Free Cash Flow Per Share	1.32	0.96	3.44	7.41	0.66	1.23
Gross Margin	93.00%	92.04%	90.93%	89.83%	87.29%	88.54%
Operating Margin	11.72%	11.50%	14.80%	15.27%	22.87%	27.43%
Profit Margin	8.52%	8.06%	-13.37%	14.59%	8.98%	11.07%
Free Cash Flow Margin	6.76%	5.45%	19.79%	42.45%	2.54%	5.86%
EBITDA	51.7	52.26	64.35	67.9	94.06	88.87
EBITDA Margin	19.06%	21.31%	26.61%	27.98%	31.71%	42.74%
D&A For EBITDA	19.92	24.05	28.57	30.84	26.23	31.84
EBIT	31.78	28.22	35.78	37.05	67.83	57.03
EBIT Margin	11.72%	11.50%	14.80%	15.27%	22.87%	27.43%
Effective Tax Rate	28.94%	28.38%	-	26.44%	41.09%	30.28%
Revenue as Reported	295.05	267.78	269.24	275.95	300.62	218.53
Advertising Expenses	-	-	-	-	-	0.77

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.